Citicoline in combined treatment of Parkinson’s disease

Written by Sayutina S.B., Shprah V.V., Rozhkova N.Y

  Индекс УДК: 616.858‑085.21 | Страницы: 76-78 | Полный текст статьи. PDF файл | Открыть PDF 


Сlinical study of citicoline efficacy and portability in the combined treatment of Parkinson’s disease has been carried out. An assignment of citicoline (600 mg during 30 days) to patients with Parkinson’s disease, receiving the basic therapy with antiparkinsonic drugs, reduced rigidity, bradykinesia and speech disturbances.

Ссылки на авторов:

S.B. Sayutina, V.V. Shprah, N.Y. Rozhkova
Irkutsk State Medical Academy of Continuing Education (100 Jubilee microdistrict, Irkutsk 664049 Russian Federation)

  1. Vasilev Yu.N., Grigoreva N.A. Phenotropil in the treatment of Parkinson’s disease // Siberian Medical Journal. 2009. No. 4. P. 53–56.
  2. Zakharov V.V. Dementia in Parkinson’s disease // Neurological Journal. 2006. Vol. 11, No. 1. P. 13–18.
  3. Katunina E.A., Malykhina E.A., Kuznetsov N.V. [et al. ] Antioxidants in combined treatment of Parkinson’s disease // Journal of Neurology and Psychiatry. 2006. No. 9. P. 22–28.
  4. Klyushnikov S.A. Neuroprotective and neurorestorative effect of Ceraxon (citicoline): review of experimental and clinical studies // Diseases of nervous system. 2012. No. 3. P. 13–20.
  5. Sayutina S.B., Shprakh V.V. Possibilities of complex correction for non‑motor disturbances in patients with Parkinson’s disease in combination with discirculatory encephalopathy // Materials of the II‑th National Congress on Parkinson’s disease and motor disturbance. M., 2011. P. 359.
  6. Yakhno N.N. Cognitive abnormalities in neurological clinics // Neurological journal. 2006. Vol. 11, No. 1. P. 4–12.
  7. Agnoli A., Ruggieri S., Denaro A., Bruno G. New strategies in the management of Parkinson’s disease: a biological approach using a phospholipid precursor (CDP‑choline) // Neuropsychobiology. 1982. No. 8. Р. 289–296.
  8. Cubells J.M., Hernando C. Clinical trial on the use of cytidine diphosphate choline in Parkinson’s disease // Clin. Ther. 1988. No. 10. Р. 664–671.
  9. Eberhardt R., Birbamer G., Gerstenbrand F. [et al.] Citicoline in the treatment of Parkinson’s disease // Clin. Ther. 1990. No. 12. Р. 489–495.
  10. Marti J.F., Urtasun M. Citicoline in the treatment of Parkinson’s disease // Clin. Ther. 1991. Vol. 13, No. 2. Р. 239–242.
  11. Petersen R.S., Smith G.E., Waring S.C. [et al.] Mild cognitive impairment: clinical characterization and outcome // Arch. Neurol. 1999. Vol. 56. Р. 303–308.
  12. Zigmond A.S., Snaith R.P. The hospital anxiety and depression scale // Acta psychiatria Scandinavica. 1983. Vol. 67, No. 6. P. 361–370.


Founded in 1997  |  Editions in a year: 4, Articles in one issue: 30 |  ISSN of print version: 1609-1175  |  Ind.: 18410 (Agency "Rospechat’")  |  Edition: 1000 c.